Single‐chain antibody variable region‐targeted interleukin‐2 stimulates T cell killing of human colorectal carcinoma cells
Authors:
- 1 August 1994
- journal article
- Published by Wiley in Immunology & Cell Biology
- Vol. 72 (4) , 275-285
Abstract
Summary: Recombinant DNA techniques were used to clone, construct and express the bifunctional molecule FV/IL‐2. The FV/IL‐2 is a single‐chain 37kDa fusion protein expressed in Escherichia coli under control of the strong T7 bacteriophage promoter in the expression vector pT7‐7‐FV‐lL‐2. The fused gene fragment FV‐IL‐2 contains a single‐chain anti‐TAG72 FV gene fragment and the human recombinant cDNA fragment of the IL‐2 molecule. The renatured soluble form of FV/IL‐2 was purified from E. coli inclusion bodies using hydroxylapatite chromatography. The yield of this fusion protein was estimated at 2.0 mg/L. Our data showed that the FV/IL‐2 molecule retained the TAG72 antigen‐binding specificity and the IL‐2 activity as measured in the standard T cell proliferation as well as cytotoxicity assays. Therefore, it may prove to be useful in targeting the biological effect of lL‐2 to tumour cells and stimulating its immune destruction.Keywords
This publication has 31 references indexed in Scilit:
- Renaturation, Purification and Characterization of Recombinant Fab-Fragments Produced in Escherichia coliNature Biotechnology, 1991
- Production of murine V-human cr1 chimeric anti-tag72 antibody using V region cdna amplified by PCRMolecular Immunology, 1990
- A comparison of strategies to stabilize immunoglobulin Fv-fragmentsBiochemistry, 1990
- Engineering monoclonal antibodiesNature, 1989
- Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coliNature, 1989
- A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxinNature, 1989
- Single-Chain Antigen-Binding ProteinsScience, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genesJournal of Molecular Biology, 1986
- Long term culture of tumour-specific cytotoxic T cellsNature, 1977